User login
Applications are due March 2, 2018, for the Wylie Scholar Award, co-sponsored by Vascular Cures and the SVS Foundation. The three-year, $150,000 grant is awarded to a promising vascular surgeon-scientist in North America and is designed to support outstanding surgeon-scientists conducting innovative academic research in the early stages of their careers.
This year's recipient, Dr. Sean English, is conducting research on AAA. Dr. Mohamed Zayed, MD, PhD, the 2015 recipient, is investigating why diabetics develop a unique lipid profile leading to PAD. For each $150,000 award, Wylie Scholars have received $3.3 million in subsequent national research funding, for a return on investment of nearly 22 to1.
Applications are due March 2, 2018, for the Wylie Scholar Award, co-sponsored by Vascular Cures and the SVS Foundation. The three-year, $150,000 grant is awarded to a promising vascular surgeon-scientist in North America and is designed to support outstanding surgeon-scientists conducting innovative academic research in the early stages of their careers.
This year's recipient, Dr. Sean English, is conducting research on AAA. Dr. Mohamed Zayed, MD, PhD, the 2015 recipient, is investigating why diabetics develop a unique lipid profile leading to PAD. For each $150,000 award, Wylie Scholars have received $3.3 million in subsequent national research funding, for a return on investment of nearly 22 to1.
Applications are due March 2, 2018, for the Wylie Scholar Award, co-sponsored by Vascular Cures and the SVS Foundation. The three-year, $150,000 grant is awarded to a promising vascular surgeon-scientist in North America and is designed to support outstanding surgeon-scientists conducting innovative academic research in the early stages of their careers.
This year's recipient, Dr. Sean English, is conducting research on AAA. Dr. Mohamed Zayed, MD, PhD, the 2015 recipient, is investigating why diabetics develop a unique lipid profile leading to PAD. For each $150,000 award, Wylie Scholars have received $3.3 million in subsequent national research funding, for a return on investment of nearly 22 to1.